NEW YORK (GenomeWeb) – Spanish healthcare products firm Grifols announced today that it has received US Food and Drug Administration approval for its blood-based alpha-1 antitrypsin (AAT) deficiency test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.